CSSi LifeSciences is a global CRO and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval, offering customized solutions that mitigate risk, time, and expense to support the U.S. market goals of companies.
With extensive knowledge and experience, CSSi LifeSciences guides novel drugs and medical devices through the complicated FDA approval process, providing a risk-based strategic roadmap for commercialization and navigating the clinical development process through all phases. Their dedicated team offers project management and commercial support services, helping accelerate products to market and providing a comprehensive suite of customized services for international life science companies transitioning to the U.S. market.
Generated from the website